ESPR vs. ONDS
ESPR (Esperion Therapeutics, Inc.) and ONDS (Ondas Holdings Inc.) are both stocks. ESPR operates in Biotechnology (Healthcare), while ONDS operates in Communication Equipment (Technology). Over the past 5 years, ESPR returned -34.62%/yr vs 2.67%/yr for ONDS. At a 0.18 correlation, their price movements are largely independent.
Performance
ESPR vs. ONDS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ESPR achieves a -14.86% return, which is significantly lower than ONDS's -4.41% return.
ESPR
- 1D
- 0.00%
- 1M
- 0.96%
- YTD
- -14.86%
- 6M
- -18.18%
- 1Y
- 162.50%
- 3Y*
- 35.36%
- 5Y*
- -34.62%
- 10Y*
- -14.95%
ONDS
- 1D
- -5.09%
- 1M
- 5.30%
- YTD
- -4.41%
- 6M
- 6.63%
- 1Y
- 445.61%
- 3Y*
- 104.56%
- 5Y*
- 2.67%
- 10Y*
- —
ESPR vs. ONDS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
ESPR Esperion Therapeutics, Inc. | -14.86% | 68.18% | -26.42% | -52.01% | 24.60% | -80.77% | -56.40% | 29.63% | 12.72% |
ONDS Ondas Holdings Inc. | -4.41% | 281.25% | 67.32% | -3.77% | -76.30% | -28.08% | -48.17% | 0.00% | 33.33% |
Correlation
The correlation between ESPR and ONDS is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.20 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Oct 25, 2018 | 0.18 |
Fundamentals
ESPR:
-$0.03
ONDS:
$1.54
ESPR:
1.75
ONDS:
15.27
ESPR:
$418.24M
ONDS:
$96.60M
ESPR:
$226.32M
ONDS:
$43.33M
ESPR:
$77.18M
ONDS:
-$75.39M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ESPR vs. ONDS — Risk / Return Rank
ESPR
ONDS
ESPR vs. ONDS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Esperion Therapeutics, Inc. (ESPR) and Ondas Holdings Inc. (ONDS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ESPR | ONDS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.78 | ||
| Sortino ratioReturn per unit of downside risk | -0.57 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 1.39 | -0.03 |
| Calmar ratioReturn relative to maximum drawdown | 3.07 | 8.42 | -5.34 |
| Martin ratioReturn relative to average drawdown | 7.68 | 18.67 | -10.99 |
Loading charts...
Drawdowns
ESPR vs. ONDS - Drawdown Comparison
The maximum ESPR drawdown since its inception was -99.37%, roughly equal to the maximum ONDS drawdown of -98.28%. Use the drawdown chart below to compare losses from any high point for ESPR and ONDS.
Loading charts...
Drawdown Indicators
| ESPR | ONDS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.37% | -98.28% | -1.09% |
Max Drawdown (1Y)Largest decline over 1 year | -53.19% | -53.37% | +0.18% |
Max Drawdown (3Y)Largest decline over 3 years | -80.94% | -83.28% | +2.34% |
Max Drawdown (5Y)Largest decline over 5 years | -97.16% | -96.99% | -0.17% |
Max Drawdown (10Y)Largest decline over 10 years | -99.10% | — | — |
Current DrawdownCurrent decline from peak | -97.27% | -52.15% | -45.12% |
Average DrawdownAverage peak-to-trough decline | -69.99% | -71.41% | +1.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.30% | 24.01% | -2.71% |
Volatility
ESPR vs. ONDS - Volatility Comparison
The current volatility for Esperion Therapeutics, Inc. (ESPR) is 1.06%, while Ondas Holdings Inc. (ONDS) has a volatility of 44.08%. This indicates that ESPR experiences smaller price fluctuations and is considered to be less risky than ONDS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ESPR | ONDS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 1.06% | 44.08% | -43.02% |
Volatility (6M)Calculated over the trailing 6-month period | 61.44% | 78.27% | -16.83% |
Volatility (1Y)Calculated over the trailing 1-year period | 92.66% | 127.45% | -34.79% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 91.79% | 113.81% | -22.02% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 84.61% | 120.73% | -36.12% |
Dividends
ESPR vs. ONDS - Dividend Comparison
Neither ESPR nor ONDS has paid dividends to shareholders.
Financials
ESPR vs. ONDS - Financials Comparison
This section allows you to compare key financial metrics between Esperion Therapeutics, Inc. and Ondas Holdings Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ESPR and ONDS have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ONDS has higher volatility (44.08%) compared to ESPR (1.06%). In terms of maximum drawdown, ESPR dropped -99.37% vs ONDS's -98.28%.
ONDS currently has the higher Sharpe Ratio (3.55 vs 1.76), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ESPR and ONDS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer